(Press-News.org) Contact information: Dr. Salvador Macip
sm460@le.ac.uk
01-162-297-113
University of Leicester
Breakthrough announced in treatment of patient with rare type of leukemia
University of Leicester researchers deploy 'precision medicine' to successfully target advanced form of leukaemia with skin cancer drug
A team of scientists from the University of Leicester has demonstrated a novel treatment for Hairy Cell Leukaemia (HCL), a rare type of blood cancer, using a drug administered to combat skin cancer.
The research, which is published today (Thursday 16 January) in the New England Journal of Medicine, indicates Vemurafenib, a BRAF inhibitor that has been approved as a treatment for advanced melanomas, is also successful in treating leukaemia. The study shows the treatment, which can be taken orally, cleared the malignant cells from the patient's blood and led to a complete clinical recovery in a number of days.
The study was led by the University of Leicester and involved treatment of a patient at the Leicester Royal Infirmary.
Dr Salvador Macip, from the University of Leicester's Department of Biochemistry, explained: "A genetic study of the patient's blood cells allowed us to identify a mutation in the BRAF gene that is commonly found in skin cancers. This knowledge enabled us to combat the cancer cells with Vemurafenib, which has had proven success as a BRAF inhibitor in melanomas, and showed similar success for this patient who had exhausted all other treatment options, which is fantastic.
"What was most surprising was that the drug did not work in the way we expected it to. Whilst it successfully blocked BRAF and killed the cancerous cells, there was no ability to block the downstream cascade of signals. Therefore more research is required to better understand how this drug works to ensure we are able to use it in the best possible way.
"This is one of the first clinical examples of this treatment for HCL and we are the first researchers to do a biochemical study of the samples and discover that the drug does not do what it's supposed to be doing."
This approach to targeting cancer is an example of precision medicine with clinicians and research scientists working side-by-side to ensure the best treatment, tailored to the individual patient, was provided.
Professor of Haemato-Oncology at the University of Leicester, Professor Martin Dyer, who is Honorary Consultant Physician, Department of Haematology at Leicester's Hospitals, said: "Precision medicine in which clinicians and basic scientists collaborate to deliver novel and rapid personalised therapies to cancer patients like this is essential.
"We drew blood from the patient on a daily basis which was analysed back in the lab to monitor the effects of the drug. The more understanding we have of how treatments such as Vemurafenib kill cancer cells, the more effective and targeted treatments can be."
Professor Dyer is based in the University of Leicester's Department of Cancer Studies and Molecular Medicine and the treatment of the patient took place at the Leicester Royal Infirmary.
This research shows that drugs currently used to target certain cancers could be applied in other malignancies that share similar genetic backgrounds.
University of Leicester Pro-Vice-Chancellor and Head of the College of Medicine, Biological Sciences and Psychology, Professor David Wynford-Thomas, said: "The importance of the close working partnership between the University of Leicester and Leicester's Hospitals is highlighted in advances such as this. World-class research at the University brings direct benefits to patients in Leicester's hospitals in diverse areas including cardiovascular health, kidney research, lung health, diabetes, cancer research and many other areas.
"I am delighted that our research has had such a direct benefit locally - it is another first for the University of Leicester and Leicester Royal Infirmary."
INFORMATION:
Breakthrough announced in treatment of patient with rare type of leukemia
University of Leicester researchers deploy 'precision medicine' to successfully target advanced form of leukaemia with skin cancer drug
2014-01-16
ELSE PRESS RELEASES FROM THIS DATE:
A deeper look at interfaces
2014-01-16
A deeper look at interfaces
Researchers at Berkeley Lab's Advanced Light Source develop new technique for probing subsurface electronic structure
"The interface is the device," Nobel laureate Herbert Kroemer famously observed, referring to the remarkable ...
Trees grow faster and store more carbon as they age
2014-01-16
Trees grow faster and store more carbon as they age
Trees put on weight faster and faster as they grow older, according to a new study in the journal Nature. The finding that most trees' growth accelerates as they age suggests that large, old trees may ...
2 diabetes studies in Jan. 2014 Health Affairs
2014-01-16
2 diabetes studies in Jan. 2014 Health Affairs
Jan. articles examine the toll of diabetes, both in the US and abroad
Poorer Americans: depleted food budgets can mean higher risk of hypoglycemia.
For generations, economists have noted that low-income households spend much ...
Researchers discover that coevolution between humans and bacteria reduces gastric cancer risk
2014-01-16
Researchers discover that coevolution between humans and bacteria reduces gastric cancer risk
Research carried out in two distinct communities in Colombia illustrates how coevolution between humans and bacteria can affect a person’s risk ...
New analysis shows fewer years of life lost to cancer
2014-01-16
New analysis shows fewer years of life lost to cancer
Dartmouth researchers say US has underestimated its progress in war on cancer
(Lebanon, NH, 1/15/14) - Since the enactment of the National Cancer Act in 1971, the U.S. has spent hundreds ...
Ray of hope for magazines in digital era
2014-01-16
Ray of hope for magazines in digital era
Targeted audiences and websites can help magazines weather the onslaught of online competition
There is a ray of hope for magazines that do it right.
While print media continue to suffer at the hands of their online counterparts, ...
Resisting the flu
2014-01-16
Resisting the flu
New avenues for influenza control suggested by identification of an enzyme that plays a crucial role in resistance to the infection
McGill researchers, led by Dr. Maya Saleh of the Department of Medicine, have identified an enzyme, cIAP2 that helps the ...
Next-gen reappraisal of interactions within a cancer-associated protein complex
2014-01-16
Next-gen reappraisal of interactions within a cancer-associated protein complex
Application of global sequencing technology reveals how an activator of gene expression stays focused
KANSAS CITY, MO- At a glance, DNA is a rather simple sequence of A, ...
Hugging hemes help electrons hop
2014-01-16
Hugging hemes help electrons hop
Novel biological mechanism relays electrons in proteins in mineral-breathing bacteria important for energy-related research
RICHLAND, Wash. -- Researchers simulating how certain bacteria run electrical current ...
Nationwide minimally invasive surgery rates triple for pancreatic disease
2014-01-16
Nationwide minimally invasive surgery rates triple for pancreatic disease
Researchers at University of California, San Diego School of Medicine report a three-fold increase in the use of minimally invasive surgery (MIS) across the nation for patients ...
LAST 30 PRESS RELEASES:
Flavanols in cocoa can protect blood vessel function following uninterrupted sitting - study
$100 Million gift will advance UCSF’s dementia research and care
The 4th Japan-India Universities Forum on 15 November
Arctic town Kiruna is colder after the move
Mayo Clinic study finds majority of midlife women with menopause symptoms do not seek care
Underwater robot ‘Lassie’ discovers remarkable icefish nests during search for Shackleton’s lost ship off Antarctica
Wearable robots you can wear like clothes: automatic weaving of “fabric muscle” brings commercialization closer
Researcher improves century-old equation to predict movement of dangerous air pollutants.
Heatwaves linked to rise in sleep apnoea cases in Europe
Down‑top strategy engineered large‑scale fluorographene/PBO nanofibers composite papers with excellent wave‑transparent performance and thermal conductivity
The Lancet: Climate change inaction being paid for in millions of lives every year
New insights reveal how coral gets a grip
Home treatment with IV antibiotics could relieve NHS pressure
AI ECG better detects severe heart attacks in emergency setting
Straw-based biochar and smart irrigation help maize thrive with less water and fertilizer
‘Broken’ genes a common factor in marsupial fur colour
Turning waste into clean water: Magnetic carbon materials remove toxic pollutants from wastewater
World Health Organization’s priorities shaped by its reliance on grants from donor organisations such as the Gates Foundation
One in ten people without coeliac disease or wheat allergy report sensitivity to gluten or wheat
How can (A)I help you?
Study finds new system can cut patient waiting times for discharge
Allison Institute’s third annual scientific symposium highlighted by panel discussion with five Nobel laureates
SETI Institute accelerates the search for life beyond earth with NVIDIA IGX Thor
Wetlands efficiently remove nitrogen pollution from surface water, leading to cost savings for municipalities
Dr. Loren Miller presents oral late breaker at IDWeek 2025 of a first-of-its-kind clinical trial that shows efficacy of bacteriophage therapy for Staphylococcus aureus bacteremia
Dirty water boosts prospects for clean hydrogen
New multisociety guidance strengthens infection prevention and control in nursing homes
More scientific analysis needed on impacts of industrial decarbonization
New research uncovers how bad bacteria know where to cluster and cause infection
As ochre sea star ‘baby boomers’ grow up, species showing signs of recovery
[Press-News.org] Breakthrough announced in treatment of patient with rare type of leukemiaUniversity of Leicester researchers deploy 'precision medicine' to successfully target advanced form of leukaemia with skin cancer drug